KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Total Current Liabilities (2016 - 2026)

AbbVie has reported Total Current Liabilities over the past 14 years, most recently at $43.3 billion for Q4 2025.

  • Quarterly Total Current Liabilities rose 11.72% to $43.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $43.3 billion through Dec 2025, up 11.72% year-over-year, with the annual reading at $43.3 billion for FY2025, 11.72% up from the prior year.
  • Total Current Liabilities was $43.3 billion for Q4 2025 at AbbVie, up from $39.4 billion in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $43.3 billion in Q4 2025 and troughed at $27.6 billion in Q1 2023.
  • The 5-year median for Total Current Liabilities is $35.0 billion (2021), against an average of $35.5 billion.
  • Year-over-year, Total Current Liabilities skyrocketed 93.98% in 2021 and then dropped 16.07% in 2022.
  • A 5-year view of Total Current Liabilities shows it stood at $35.2 billion in 2021, then dropped by 16.07% to $29.5 billion in 2022, then increased by 28.11% to $37.8 billion in 2023, then grew by 2.4% to $38.7 billion in 2024, then grew by 11.72% to $43.3 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Total Current Liabilities are $43.3 billion (Q4 2025), $39.4 billion (Q3 2025), and $39.8 billion (Q2 2025).